AMGN
Amgen Inc$387.64updated Jul 31, 2026
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Total Trades
31
Politicians Trading
13
Last Traded
Jun 30, 2026
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Jul 6, 2026 | Jun 30, 2026 | Buy | $1,001 - $15,000 | +7.05% |
| Ro KhannaD | Jul 6, 2026 | Jun 16, 2026 | Buy | $1,001 - $15,000 | +11.44% |
| David TaylorR | Jun 12, 2026 | Jun 5, 2026 | Buy | $1,001 - $15,000 | +10.89% |
| Ro KhannaD | Jul 6, 2026 | Jun 2, 2026 | Buy | $1,001 - $15,000 | +18.09% |
| Ro KhannaD | Jun 9, 2026 | May 27, 2026 | Buy | $15,001 - $50,000 | +15.35% |
| Ro KhannaD | Jun 9, 2026 | May 15, 2026 | Sell | $15,001 - $50,000 | +18.80% |
| Ro KhannaD | Jun 9, 2026 | May 1, 2026 | Buy | $15,001 - $50,000 | +17.53% |
| Ro KhannaD | May 11, 2026 | Apr 24, 2026 | Sell | $15,001 - $50,000 | +12.51% |
| Alan ArmstrongR | Jul 21, 2026 | Mar 27, 2026 | Sell | $15,001 - $50,000 | +11.14% |
| David TaylorR | Mar 6, 2026 | Feb 26, 2026 | Sell | $1,001 - $15,000 | +2.19% |
| David TaylorR | Feb 2, 2026 | Jan 29, 2026 | Sell | $1,001 - $15,000 | +13.03% |
| David TaylorR | Feb 2, 2026 | Jan 16, 2026 | Buy | $1,001 - $15,000 | +17.32% |
| David TaylorR | Dec 5, 2025 | Dec 3, 2025 | Sell | $1,001 - $15,000 | +12.22% |
| David TaylorR | Dec 5, 2025 | Dec 3, 2025 | Sell | $1,001 - $15,000 | +12.22% |
| Marjorie Taylor GreeneR | Oct 28, 2025 | Oct 24, 2025 | Buy | $1,001 - $15,000 | +32.86% |
| Lisa C. McClainR | Oct 22, 2025 | Sep 25, 2025 | Sell | $1,001 - $15,000 | +42.95% |
| Marjorie Taylor GreeneR | Sep 27, 2025 | Sep 11, 2025 | Buy | $1,001 - $15,000 | +37.11% |
| Sheldon WhitehouseD | Oct 3, 2025 | Sep 4, 2025 | Sell | $1,001 - $15,000 | +38.39% |
| Lisa C. McClainR | Aug 13, 2025 | Jun 24, 2025 | Buy | $1,001 - $15,000 | +39.70% |
| Cliff BentzR | Jul 9, 2025 | Jun 6, 2025 | Buy | $1,001 - $15,000 | +33.52% |
| Marjorie Taylor GreeneR | May 19, 2025 | May 14, 2025 | Buy | $1,001 - $15,000 | +47.80% |
| Jefferson ShreveR | Jun 22, 2025 | May 12, 2025 | Sell | $15,001 - $50,000 | +41.08% |
| Marjorie Taylor GreeneR | May 6, 2025 | May 5, 2025 | Buy | $1,001 - $15,000 | +38.41% |
| Jared MoskowitzD | May 9, 2025 | Apr 16, 2025 | Buy | $1,001 - $15,000 | +37.15% |
| Jared MoskowitzD | May 9, 2025 | Apr 16, 2025 | Buy | $1,001 - $15,000 | +37.15% |
| Tommy TubervilleR | May 15, 2025 | Apr 15, 2025 | Sell | $15,001 - $50,000 | +31.27% |
| Jefferson ShreveR | May 8, 2025 | Apr 11, 2025 | Buy | $15,001 - $50,000 | +35.55% |
| Robert BresnahanR | May 8, 2025 | Apr 8, 2025 | Sell | $1,001 - $15,000 | +38.31% |
| Jefferson ShreveR | Mar 9, 2025 | Feb 24, 2025 | Buy | $15,001 - $50,000 | +25.16% |
| Daniel MeuserR | Aug 20, 2025 | Feb 11, 2025 | Sell | $1,001 - $15,000 | +30.67% |
| Emily RandallD | Feb 11, 2025 | Jan 6, 2025 | Sell | $1,001 - $15,000 | +49.91% |